Mutations

TREM2 D131D

Overview

Pathogenicity: Alzheimer's Disease : Benign
Position: (GRCh38/hg38):Chr6:41159881 C>T
Position: (GRCh37/hg19):Chr6:41127619 C>T
dbSNP ID: rs139607688
Coding/Non-Coding: Coding
DNA Change: Substitution
Expected RNA Consequence: Substitution
Expected Protein Consequence: Silent
Codon Change: GAC to GAT
Reference Isoform: TREM2 Isoform 1 (230 aa)
Genomic Region: Exon 3

Findings

The D131D variant was not associated with AD in a case-control study of more than 33,000 Caucasian subjects (approximately 18,000 AD and 16,000 controls; odds ratio: 5.69, p = 0.39) (Sims et al., 2017).

Neuropathology

No data.

Biological Effect

No data.

Last Updated: 07 Feb 2018

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

Paper Citations

  1. . Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 Sep;49(9):1373-1384. Epub 2017 Jul 17 PubMed.

Further Reading

No Available Further Reading

Protein Diagram

Primary Papers

  1. . Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 Sep;49(9):1373-1384. Epub 2017 Jul 17 PubMed.

Alzpedia

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.